PATLY.AIApplication
18339565 · CD20 THERAPIES, CD22 THERAPIES, AND COMBINATION THERAPIES WITH A CD19 CHIMERIC ANTIGEN RECEPTOR (CAR)-EXPRESSING CELL
Filed 2023-06-22 · Pending The official file ↗ · Art unit 1646 · Examiner Peter J Reddig Typical · CPC A61P 35/00 · The Trustees of the University of Pennsylvania · K&L Gates - Novartis
Office actions
2
first was Restriction requirement
RCEs
0
no appeal
To first action
21.2 mo
to disposition n/a
Statutes raised
103 DP
2 actions read